Karen Beenken
Concepts (237)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Staphylococcus aureus | 42 | 2024 | 326 | 4.350 |
Why?
| Bacterial Proteins | 29 | 2024 | 376 | 3.250 |
Why?
| Biofilms | 33 | 2024 | 181 | 3.250 |
Why?
| Staphylococcal Infections | 25 | 2024 | 268 | 2.790 |
Why?
| Osteomyelitis | 14 | 2024 | 126 | 2.330 |
Why?
| Anti-Bacterial Agents | 19 | 2023 | 744 | 2.140 |
Why?
| Trans-Activators | 13 | 2021 | 134 | 1.830 |
Why?
| Gene Expression Regulation, Bacterial | 22 | 2024 | 191 | 1.720 |
Why?
| Peptide Hydrolases | 11 | 2024 | 62 | 1.610 |
Why?
| Chitosan | 7 | 2021 | 34 | 1.360 |
Why?
| Drug Delivery Systems | 3 | 2021 | 138 | 0.890 |
Why?
| Daptomycin | 6 | 2016 | 29 | 0.880 |
Why?
| Virulence Factors | 7 | 2024 | 78 | 0.840 |
Why?
| Disease Models, Animal | 15 | 2024 | 1455 | 0.770 |
Why?
| Bone Regeneration | 1 | 2021 | 68 | 0.740 |
Why?
| Protein Kinases | 3 | 2019 | 71 | 0.720 |
Why?
| Mutation | 21 | 2023 | 1294 | 0.710 |
Why?
| Virulence | 14 | 2024 | 173 | 0.700 |
Why?
| Vancomycin | 7 | 2021 | 81 | 0.670 |
Why?
| Methicillin-Resistant Staphylococcus aureus | 4 | 2018 | 76 | 0.640 |
Why?
| Animals | 36 | 2024 | 13187 | 0.600 |
Why?
| Prosthesis-Related Infections | 2 | 2017 | 104 | 0.550 |
Why?
| Catheter-Related Infections | 7 | 2016 | 49 | 0.550 |
Why?
| Mice | 28 | 2024 | 5739 | 0.550 |
Why?
| Polymethyl Methacrylate | 2 | 2014 | 26 | 0.530 |
Why?
| Deoxyribonucleases | 3 | 2015 | 23 | 0.530 |
Why?
| Gene Expression Regulation, Enzymologic | 2 | 2016 | 181 | 0.490 |
Why?
| Amikacin | 4 | 2018 | 19 | 0.470 |
Why?
| Rabbits | 5 | 2021 | 370 | 0.460 |
Why?
| Delayed-Action Preparations | 2 | 2016 | 47 | 0.450 |
Why?
| Escherichia coli Proteins | 2 | 2005 | 56 | 0.450 |
Why?
| Xylitol | 1 | 2012 | 7 | 0.430 |
Why?
| Drug Carriers | 3 | 2017 | 67 | 0.410 |
Why?
| Coated Materials, Biocompatible | 3 | 2017 | 33 | 0.390 |
Why?
| Pseudomonas aeruginosa | 5 | 2017 | 72 | 0.390 |
Why?
| Microbial Sensitivity Tests | 10 | 2023 | 269 | 0.380 |
Why?
| Bacteremia | 4 | 2017 | 90 | 0.370 |
Why?
| Epistasis, Genetic | 1 | 2010 | 29 | 0.360 |
Why?
| Phenotype | 7 | 2021 | 729 | 0.300 |
Why?
| Metalloendopeptidases | 3 | 2024 | 70 | 0.300 |
Why?
| Lipoproteins | 2 | 2012 | 39 | 0.290 |
Why?
| Bacterial Outer Membrane Proteins | 1 | 2005 | 22 | 0.270 |
Why?
| Gram-Negative Bacteria | 1 | 2005 | 34 | 0.260 |
Why?
| Osteoclasts | 3 | 2024 | 425 | 0.250 |
Why?
| Carrier Proteins | 2 | 2005 | 304 | 0.240 |
Why?
| Endopeptidases | 2 | 2023 | 66 | 0.240 |
Why?
| Escherichia coli | 2 | 2005 | 186 | 0.240 |
Why?
| Membrane Proteins | 1 | 2005 | 341 | 0.220 |
Why?
| Gene Expression Profiling | 2 | 2006 | 1032 | 0.220 |
Why?
| RANK Ligand | 1 | 2024 | 179 | 0.220 |
Why?
| Polyethylene Glycols | 3 | 2021 | 93 | 0.220 |
Why?
| RNA, Bacterial | 5 | 2011 | 58 | 0.200 |
Why?
| Ethylnitrosourea | 1 | 2001 | 9 | 0.200 |
Why?
| Methylnitrosourea | 1 | 2001 | 10 | 0.200 |
Why?
| Alkylating Agents | 1 | 2001 | 23 | 0.200 |
Why?
| Methyltransferases | 1 | 2001 | 27 | 0.200 |
Why?
| Bone Resorption | 1 | 2024 | 304 | 0.200 |
Why?
| Extracellular Space | 4 | 2021 | 38 | 0.200 |
Why?
| Gentamicins | 1 | 2021 | 31 | 0.190 |
Why?
| Proteomics | 3 | 2019 | 329 | 0.190 |
Why?
| Durapatite | 1 | 2021 | 24 | 0.190 |
Why?
| X-Ray Microtomography | 1 | 2021 | 77 | 0.190 |
Why?
| Tissue Scaffolds | 1 | 2021 | 33 | 0.190 |
Why?
| Biocompatible Materials | 2 | 2021 | 69 | 0.190 |
Why?
| Chronic Disease | 2 | 2014 | 567 | 0.190 |
Why?
| Bacterial Infections | 2 | 2018 | 95 | 0.180 |
Why?
| Repressor Proteins | 1 | 2021 | 151 | 0.170 |
Why?
| Bacterial Toxins | 3 | 2020 | 52 | 0.170 |
Why?
| Gold | 2 | 2018 | 136 | 0.160 |
Why?
| Osteogenesis | 1 | 2021 | 352 | 0.160 |
Why?
| Biopolymers | 1 | 2018 | 14 | 0.160 |
Why?
| Ciprofloxacin | 1 | 2018 | 21 | 0.160 |
Why?
| RNA, Messenger | 4 | 2011 | 1105 | 0.150 |
Why?
| Rifampin | 1 | 2018 | 62 | 0.150 |
Why?
| Coinfection | 1 | 2018 | 38 | 0.150 |
Why?
| Phosphatidylcholines | 1 | 2017 | 25 | 0.150 |
Why?
| Fatty Acids, Monounsaturated | 1 | 2017 | 15 | 0.150 |
Why?
| Bone and Bones | 1 | 2021 | 469 | 0.150 |
Why?
| Proteome | 1 | 2018 | 173 | 0.140 |
Why?
| Humans | 22 | 2024 | 49974 | 0.140 |
Why?
| Nanoparticles | 1 | 2018 | 145 | 0.140 |
Why?
| Recombinases | 1 | 2016 | 9 | 0.140 |
Why?
| Peptides, Cyclic | 1 | 2016 | 41 | 0.130 |
Why?
| Sigma Factor | 1 | 2016 | 22 | 0.130 |
Why?
| Cephalosporins | 1 | 2016 | 41 | 0.130 |
Why?
| Serine Endopeptidases | 2 | 2014 | 52 | 0.130 |
Why?
| Prostheses and Implants | 1 | 2015 | 54 | 0.130 |
Why?
| Genetic Loci | 1 | 2015 | 49 | 0.120 |
Why?
| Calcium Sulfate | 1 | 2014 | 7 | 0.120 |
Why?
| Amphotericin B | 1 | 2014 | 110 | 0.120 |
Why?
| Cysteine Endopeptidases | 1 | 2014 | 67 | 0.120 |
Why?
| Materials Testing | 1 | 2014 | 58 | 0.120 |
Why?
| Plant Extracts | 2 | 2012 | 190 | 0.110 |
Why?
| Transcription Factors | 2 | 2014 | 561 | 0.110 |
Why?
| Hemolysin Proteins | 2 | 2011 | 15 | 0.110 |
Why?
| Protease Inhibitors | 2 | 2010 | 58 | 0.110 |
Why?
| Quercus | 1 | 2012 | 8 | 0.110 |
Why?
| Debridement | 1 | 2012 | 46 | 0.100 |
Why?
| Magnetite Nanoparticles | 1 | 2012 | 21 | 0.100 |
Why?
| Bone Cements | 1 | 2012 | 31 | 0.100 |
Why?
| Radius | 1 | 2012 | 28 | 0.100 |
Why?
| Carotenoids | 1 | 2012 | 49 | 0.100 |
Why?
| RNA Stability | 1 | 2012 | 24 | 0.100 |
Why?
| Ellagic Acid | 1 | 2012 | 6 | 0.100 |
Why?
| Rosaceae | 1 | 2012 | 9 | 0.100 |
Why?
| Antifungal Agents | 1 | 2014 | 339 | 0.100 |
Why?
| Drug Resistance, Multiple, Bacterial | 2 | 2016 | 63 | 0.100 |
Why?
| Surgical Wound Infection | 1 | 2012 | 115 | 0.100 |
Why?
| Ribonuclease P | 1 | 2011 | 3 | 0.100 |
Why?
| Radiopharmaceuticals | 1 | 2012 | 209 | 0.100 |
Why?
| Fluorodeoxyglucose F18 | 1 | 2012 | 192 | 0.100 |
Why?
| RNA-Binding Proteins | 1 | 2012 | 123 | 0.090 |
Why?
| RNA Processing, Post-Transcriptional | 1 | 2011 | 24 | 0.090 |
Why?
| Polysaccharides, Bacterial | 1 | 2010 | 13 | 0.090 |
Why?
| Adhesins, Bacterial | 3 | 2012 | 27 | 0.090 |
Why?
| Anti-Infective Agents | 1 | 2011 | 95 | 0.090 |
Why?
| Mice, Inbred C57BL | 3 | 2020 | 1816 | 0.080 |
Why?
| Dose-Response Relationship, Drug | 1 | 2012 | 1376 | 0.080 |
Why?
| Male | 6 | 2014 | 25241 | 0.080 |
Why?
| Adaptation, Physiological | 2 | 2006 | 91 | 0.070 |
Why?
| Models, Biological | 2 | 2011 | 727 | 0.070 |
Why?
| Operon | 2 | 2016 | 29 | 0.070 |
Why?
| Chromatography, High Pressure Liquid | 2 | 2018 | 349 | 0.070 |
Why?
| Membrane Fusion Proteins | 1 | 2005 | 1 | 0.070 |
Why?
| Biological Transport, Active | 1 | 2005 | 30 | 0.070 |
Why?
| Multidrug Resistance-Associated Proteins | 1 | 2005 | 17 | 0.070 |
Why?
| Catheters | 2 | 2016 | 31 | 0.070 |
Why?
| Osteoblasts | 2 | 2020 | 450 | 0.070 |
Why?
| Membrane Transport Proteins | 1 | 2005 | 49 | 0.070 |
Why?
| Female | 7 | 2021 | 26472 | 0.060 |
Why?
| Brain | 1 | 2013 | 1328 | 0.060 |
Why?
| Arthritis, Infectious | 2 | 2003 | 44 | 0.060 |
Why?
| Protein Conformation | 1 | 2005 | 166 | 0.060 |
Why?
| Transcription, Genetic | 2 | 2003 | 369 | 0.060 |
Why?
| Plankton | 1 | 2004 | 5 | 0.060 |
Why?
| Anaerobiosis | 1 | 2004 | 18 | 0.060 |
Why?
| Models, Molecular | 1 | 2005 | 338 | 0.060 |
Why?
| Colony Count, Microbial | 1 | 2004 | 66 | 0.060 |
Why?
| Genes, Bacterial | 1 | 2004 | 64 | 0.060 |
Why?
| Methicillin | 1 | 2024 | 11 | 0.060 |
Why?
| Hydrogen-Ion Concentration | 1 | 2004 | 175 | 0.060 |
Why?
| Mammals | 1 | 2024 | 56 | 0.060 |
Why?
| Femur | 1 | 2024 | 133 | 0.060 |
Why?
| Catheterization | 1 | 2004 | 96 | 0.060 |
Why?
| Mice, Inbred BALB C | 1 | 2004 | 304 | 0.060 |
Why?
| Down-Regulation | 1 | 2004 | 348 | 0.050 |
Why?
| Musculoskeletal Diseases | 1 | 2003 | 46 | 0.050 |
Why?
| Antibodies, Monoclonal, Humanized | 1 | 2024 | 225 | 0.050 |
Why?
| Up-Regulation | 1 | 2004 | 452 | 0.050 |
Why?
| Alkylation | 1 | 2001 | 11 | 0.050 |
Why?
| Mutagenesis | 1 | 2001 | 60 | 0.050 |
Why?
| Staphylococcus | 1 | 2001 | 35 | 0.050 |
Why?
| Research Design | 1 | 2023 | 344 | 0.050 |
Why?
| Mannitol | 1 | 2021 | 14 | 0.050 |
Why?
| DNA Transposable Elements | 1 | 2021 | 107 | 0.050 |
Why?
| Titanium | 1 | 2021 | 48 | 0.050 |
Why?
| Disease Susceptibility | 1 | 2021 | 89 | 0.050 |
Why?
| Polymerase Chain Reaction | 1 | 2001 | 453 | 0.040 |
Why?
| Gene Expression | 1 | 2001 | 609 | 0.040 |
Why?
| Sepsis | 1 | 2021 | 220 | 0.040 |
Why?
| Genotype | 1 | 2020 | 537 | 0.040 |
Why?
| Drug Combinations | 1 | 2017 | 123 | 0.040 |
Why?
| Tandem Mass Spectrometry | 1 | 2018 | 236 | 0.040 |
Why?
| Teicoplanin | 1 | 2016 | 4 | 0.040 |
Why?
| Glycopeptides | 1 | 2016 | 10 | 0.040 |
Why?
| Aminoglycosides | 1 | 2016 | 18 | 0.040 |
Why?
| Analysis of Variance | 1 | 2018 | 562 | 0.030 |
Why?
| Freeze Drying | 1 | 2016 | 7 | 0.030 |
Why?
| Drug Evaluation, Preclinical | 1 | 2016 | 144 | 0.030 |
Why?
| Drug Compounding | 1 | 2016 | 24 | 0.030 |
Why?
| Polytetrafluoroethylene | 1 | 2016 | 32 | 0.030 |
Why?
| Acetates | 1 | 2016 | 49 | 0.030 |
Why?
| Drug Resistance, Bacterial | 1 | 2016 | 71 | 0.030 |
Why?
| Regulatory Sequences, Nucleic Acid | 1 | 2015 | 40 | 0.030 |
Why?
| Porifera | 1 | 2014 | 2 | 0.030 |
Why?
| Musculoskeletal System | 1 | 2014 | 16 | 0.030 |
Why?
| Point-of-Care Systems | 1 | 2015 | 56 | 0.030 |
Why?
| Cerebral Ventricles | 1 | 2013 | 28 | 0.030 |
Why?
| Plant Stems | 1 | 2012 | 11 | 0.030 |
Why?
| Animals, Outbred Strains | 1 | 2012 | 11 | 0.030 |
Why?
| Staphylococcal Protein A | 1 | 2012 | 7 | 0.030 |
Why?
| Photochemical Processes | 1 | 2012 | 9 | 0.030 |
Why?
| Color | 1 | 2012 | 22 | 0.030 |
Why?
| Plant Leaves | 1 | 2012 | 43 | 0.030 |
Why?
| Skin | 1 | 2016 | 409 | 0.030 |
Why?
| Complementary Therapies | 1 | 2012 | 25 | 0.030 |
Why?
| Light | 1 | 2012 | 71 | 0.030 |
Why?
| Molecular Imaging | 1 | 2012 | 53 | 0.030 |
Why?
| Antibodies | 1 | 2012 | 154 | 0.030 |
Why?
| Chromatin Immunoprecipitation | 1 | 2012 | 49 | 0.030 |
Why?
| Lasers | 1 | 2012 | 123 | 0.030 |
Why?
| Electrophoretic Mobility Shift Assay | 1 | 2012 | 73 | 0.030 |
Why?
| Mice, Nude | 1 | 2012 | 252 | 0.030 |
Why?
| Chemical Fractionation | 1 | 2012 | 17 | 0.030 |
Why?
| Biological Assay | 1 | 2012 | 45 | 0.030 |
Why?
| Photoacoustic Techniques | 1 | 2012 | 72 | 0.020 |
Why?
| Microscopy, Confocal | 1 | 2012 | 88 | 0.020 |
Why?
| Glycosylation | 1 | 2012 | 100 | 0.020 |
Why?
| Hot Temperature | 1 | 2012 | 207 | 0.020 |
Why?
| Fruit | 1 | 2012 | 136 | 0.020 |
Why?
| Antibiotic Prophylaxis | 1 | 2012 | 61 | 0.020 |
Why?
| Hep G2 Cells | 1 | 2011 | 36 | 0.020 |
Why?
| Cell Death | 1 | 2012 | 181 | 0.020 |
Why?
| Blotting, Western | 1 | 2012 | 601 | 0.020 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 595 | 0.020 |
Why?
| Chromatography, Liquid | 1 | 2012 | 232 | 0.020 |
Why?
| Small Molecule Libraries | 1 | 2011 | 68 | 0.020 |
Why?
| Positron-Emission Tomography | 1 | 2012 | 295 | 0.020 |
Why?
| Mass Spectrometry | 1 | 2012 | 306 | 0.020 |
Why?
| Protein Binding | 1 | 2012 | 660 | 0.020 |
Why?
| Genetic Variation | 1 | 2011 | 213 | 0.020 |
Why?
| Phenols | 1 | 2011 | 113 | 0.020 |
Why?
| Inflammation | 1 | 2013 | 604 | 0.020 |
Why?
| Cell Line | 1 | 2012 | 1000 | 0.020 |
Why?
| Acetoin | 1 | 2008 | 2 | 0.020 |
Why?
| Micrococcal Nuclease | 1 | 2008 | 7 | 0.020 |
Why?
| Butylene Glycols | 1 | 2008 | 14 | 0.020 |
Why?
| Genetic Complementation Test | 1 | 2008 | 47 | 0.020 |
Why?
| Postoperative Complications | 1 | 2013 | 984 | 0.020 |
Why?
| Regulon | 1 | 2006 | 8 | 0.020 |
Why?
| Cell Survival | 1 | 2008 | 600 | 0.020 |
Why?
| Rats | 1 | 2012 | 3305 | 0.020 |
Why?
| Gene Deletion | 1 | 2006 | 266 | 0.020 |
Why?
| Oligonucleotide Array Sequence Analysis | 1 | 2006 | 411 | 0.020 |
Why?
| RNA, Antisense | 1 | 2002 | 6 | 0.010 |
Why?
| Lipase | 1 | 2002 | 13 | 0.010 |
Why?
| Hemolysis | 1 | 2002 | 27 | 0.010 |
Why?
| Fibronectins | 1 | 2002 | 39 | 0.010 |
Why?
| Genes, rRNA | 1 | 2001 | 8 | 0.010 |
Why?
| Blood | 1 | 2001 | 28 | 0.010 |
Why?
| Culture Media | 1 | 2001 | 94 | 0.010 |
Why?
| Child | 1 | 2013 | 6847 | 0.010 |
Why?
| DNA Primers | 1 | 2001 | 207 | 0.010 |
Why?
| Collagen | 1 | 2002 | 206 | 0.010 |
Why?
| Incidence | 1 | 2003 | 1003 | 0.010 |
Why?
| Severity of Illness Index | 1 | 2003 | 945 | 0.010 |
Why?
| Sensitivity and Specificity | 1 | 2001 | 861 | 0.010 |
Why?
|
|
Beenken's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|